Intravenous renal cell transplantation with SAA1-positive cells prevents the progression of chronic renal failure in rats with ischemic-diabetic nephropathy

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Diabetic nephropa-thy, the most common cause of progressive chronic renal failure and end-stage renal disease, has now reached global proportions. The only means to rescue diabetic patients on dialysis is renal transplantation, a very effective therapy but severely limited by the availability of donor kidneys. Hence, we tested the role of intravenous renal cell transplantation (IRCT) on obese/diabetic Zucker/SHHF F1 hybrid (ZS) female rats with severe ischemic and diabetic nephropathy. Renal ischemia was produced by bilateral renal clamping of the renal arteries at 10 wk of age, and IRCT with genetically modified normal ZS male tubular cells was given intravenously at 15 and 20 wk of age. Rats were euthanized at 34 wk of age. IRCT with cells expressing serum amyloid A had strong and long-lasting beneficial effects on renal function and structure, including tubules and glomeruli. However, donor cells were found engrafted only in renal tubules 14 wk after the second infusion. The results indicate that IRCT with serum amyloid A-positive cells is effective in preventing the progression of chronic kidney disease in rats with diabetic and ischemic nephropathy.

Original languageEnglish
JournalAmerican Journal of Physiology - Renal Physiology
Volume305
Issue number12
DOIs
StatePublished - Dec 15 2013

Fingerprint

Cell Transplantation
Diabetic Nephropathies
Kidney Transplantation
Chronic Kidney Failure
Kidney
Serum Amyloid A Protein
Tissue Donors
Renal Artery
Chronic Renal Insufficiency
Constriction
Dialysis
Ischemia

Keywords

  • Chronic renal failure
  • Diabetic nephropathies
  • Organ regeneration
  • Serum amyloid A

ASJC Scopus subject areas

  • Physiology
  • Urology

Cite this

@article{c2c73e7b0ce64043b50817d5e60a470d,
title = "Intravenous renal cell transplantation with SAA1-positive cells prevents the progression of chronic renal failure in rats with ischemic-diabetic nephropathy",
abstract = "Diabetic nephropa-thy, the most common cause of progressive chronic renal failure and end-stage renal disease, has now reached global proportions. The only means to rescue diabetic patients on dialysis is renal transplantation, a very effective therapy but severely limited by the availability of donor kidneys. Hence, we tested the role of intravenous renal cell transplantation (IRCT) on obese/diabetic Zucker/SHHF F1 hybrid (ZS) female rats with severe ischemic and diabetic nephropathy. Renal ischemia was produced by bilateral renal clamping of the renal arteries at 10 wk of age, and IRCT with genetically modified normal ZS male tubular cells was given intravenously at 15 and 20 wk of age. Rats were euthanized at 34 wk of age. IRCT with cells expressing serum amyloid A had strong and long-lasting beneficial effects on renal function and structure, including tubules and glomeruli. However, donor cells were found engrafted only in renal tubules 14 wk after the second infusion. The results indicate that IRCT with serum amyloid A-positive cells is effective in preventing the progression of chronic kidney disease in rats with diabetic and ischemic nephropathy.",
keywords = "Chronic renal failure, Diabetic nephropathies, Organ regeneration, Serum amyloid A",
author = "Katherine Kelly and Jizhong Zhang and Ling Han and Mingsheng Wang and Shaobo Zhang and Jesus Dominguez",
year = "2013",
month = "12",
day = "15",
doi = "10.1152/ajprenal.00097.2013",
language = "English",
volume = "305",
journal = "American Journal of Physiology",
issn = "0193-1857",
publisher = "American Physiological Society",
number = "12",

}

TY - JOUR

T1 - Intravenous renal cell transplantation with SAA1-positive cells prevents the progression of chronic renal failure in rats with ischemic-diabetic nephropathy

AU - Kelly, Katherine

AU - Zhang, Jizhong

AU - Han, Ling

AU - Wang, Mingsheng

AU - Zhang, Shaobo

AU - Dominguez, Jesus

PY - 2013/12/15

Y1 - 2013/12/15

N2 - Diabetic nephropa-thy, the most common cause of progressive chronic renal failure and end-stage renal disease, has now reached global proportions. The only means to rescue diabetic patients on dialysis is renal transplantation, a very effective therapy but severely limited by the availability of donor kidneys. Hence, we tested the role of intravenous renal cell transplantation (IRCT) on obese/diabetic Zucker/SHHF F1 hybrid (ZS) female rats with severe ischemic and diabetic nephropathy. Renal ischemia was produced by bilateral renal clamping of the renal arteries at 10 wk of age, and IRCT with genetically modified normal ZS male tubular cells was given intravenously at 15 and 20 wk of age. Rats were euthanized at 34 wk of age. IRCT with cells expressing serum amyloid A had strong and long-lasting beneficial effects on renal function and structure, including tubules and glomeruli. However, donor cells were found engrafted only in renal tubules 14 wk after the second infusion. The results indicate that IRCT with serum amyloid A-positive cells is effective in preventing the progression of chronic kidney disease in rats with diabetic and ischemic nephropathy.

AB - Diabetic nephropa-thy, the most common cause of progressive chronic renal failure and end-stage renal disease, has now reached global proportions. The only means to rescue diabetic patients on dialysis is renal transplantation, a very effective therapy but severely limited by the availability of donor kidneys. Hence, we tested the role of intravenous renal cell transplantation (IRCT) on obese/diabetic Zucker/SHHF F1 hybrid (ZS) female rats with severe ischemic and diabetic nephropathy. Renal ischemia was produced by bilateral renal clamping of the renal arteries at 10 wk of age, and IRCT with genetically modified normal ZS male tubular cells was given intravenously at 15 and 20 wk of age. Rats were euthanized at 34 wk of age. IRCT with cells expressing serum amyloid A had strong and long-lasting beneficial effects on renal function and structure, including tubules and glomeruli. However, donor cells were found engrafted only in renal tubules 14 wk after the second infusion. The results indicate that IRCT with serum amyloid A-positive cells is effective in preventing the progression of chronic kidney disease in rats with diabetic and ischemic nephropathy.

KW - Chronic renal failure

KW - Diabetic nephropathies

KW - Organ regeneration

KW - Serum amyloid A

UR - http://www.scopus.com/inward/record.url?scp=84890377276&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84890377276&partnerID=8YFLogxK

U2 - 10.1152/ajprenal.00097.2013

DO - 10.1152/ajprenal.00097.2013

M3 - Article

C2 - 24133118

AN - SCOPUS:84890377276

VL - 305

JO - American Journal of Physiology

JF - American Journal of Physiology

SN - 0193-1857

IS - 12

ER -